Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Brain Res ; 184(3): 435-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18030453

ABSTRACT

Peroxynitrite (ONOO(-)) and species derived from it can oxidize and nitrate lipids, proteins and DNA leading to changes in signaling molecules. The present study was carried out to elucidate possible effects of CNS peroxynitrite in a mouse model of orofacial pain. Mice that received facial carrageenan injection + intracerebroventricular (i.c.v.) injection of the peroxynitrite scavenger [5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato iron (III), chloride] (FeTPPS) showed significantly fewer face wash strokes upon probing the inflamed area of the face with a von Frey hair at 6 h after injection, compared to mice that received facial carrageenan alone, or facial carrageenan injection + i.c.v. injection of saline. Mice that received i.c.v. injection of FeTPPS without facial carrageenan injection showed no significant difference in response to von Frey hair stimulation, compared to mice that received i.c.v. injection of saline without facial carrageenan injection. These results indicate an anti-nociceptive effect of the peroxynitrite scavenger FeTPPS in carrageenan induced facial pain but no effect on normal tactile sensation and point to an important role of CNS peroxynitrite in nociception.


Subject(s)
Facial Pain/drug therapy , Free Radical Scavengers/pharmacology , Metalloporphyrins/pharmacology , Nociceptors/drug effects , Oxidative Stress/drug effects , Peroxynitrous Acid/antagonists & inhibitors , Animals , Brain/drug effects , Brain/metabolism , Brain/physiopathology , Carrageenan/adverse effects , Carrageenan/antagonists & inhibitors , Disease Models, Animal , Facial Pain/chemically induced , Facial Pain/physiopathology , Free Radical Scavengers/therapeutic use , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/physiopathology , Inflammation Mediators/adverse effects , Inflammation Mediators/antagonists & inhibitors , Male , Mechanoreceptors/drug effects , Mechanoreceptors/physiology , Metalloporphyrins/therapeutic use , Mice , Mice, Inbred C57BL , Nitric Oxide/metabolism , Nociceptors/metabolism , Oxidative Stress/physiology , Pain Measurement/drug effects , Pain Threshold/drug effects , Pain Threshold/physiology , Peroxynitrous Acid/metabolism , Physical Stimulation , Touch/drug effects , Touch/physiology , Treatment Outcome , Trigeminal Nerve/drug effects , Trigeminal Nerve/metabolism , Trigeminal Nerve/physiopathology
2.
Neurochem Res ; 31(1): 41-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16474995

ABSTRACT

The fusion of synaptic vesicles with the plasma membrane during exocytosis can be recorded by membrane capacitance measurements under voltage-clamp conditions. These measurements enable high time-resolution quantitation of exocytosis. The present study was carried out using the above technique to elucidate the effects of various polyunsaturated fatty acids on exocytosis in a neuroendocrine cell, the rat pheochromocytoma-12 (PC12) cell. External application of eicosapentaenoic acid and arachidonic acid resulted in an increase in capacitance of PC12 cells, indicating fusion of secretory vesicles with cell membranes and exocytosis. In contrast, docosahexaenoic acid, linoleic acid, oleic acid, and vehicle control had no significant effect on capacitance. The above findings show differential effects of polyunsaturated fatty acids on exocytosis in PC12 cells. It is postulated that besides arachidonic acid, eicosapentaenoic acid could also play an important role in exocytosis and neurotransmitter release, in neurons and hormone-secreting cells.


Subject(s)
Cell Membrane/metabolism , Electric Capacitance , Exocytosis/physiology , Fatty Acids, Unsaturated/metabolism , Animals , Fatty Acids, Unsaturated/chemistry , Membrane Fusion/physiology , PC12 Cells , Patch-Clamp Techniques , Rats , Synaptic Vesicles/metabolism
3.
Reprod Nutr Dev ; 45(5): 647-62, 2005.
Article in English | MEDLINE | ID: mdl-16188213

ABSTRACT

The present study was carried out to elucidate the effect of a single episode of oxidative stress on pyramidal neurons of the rat hippocampus. A significant increase in the number of neurons that were immunolabeled for the toxic lipid peroxidation product, 4-hydroxynonenal (HNE) was observed in field CA3 of the hippocampus, at 1 day, 7 days and 14 days after intracerebroventricular injection of 1 microL of 5 mM ferrous ammonium citrate, compared to ammonium citrate injected controls at these time points. The number of HNE positive cells was fewer at 14 days, compared to 1 day, after ferrous ammonium citrate injection. The changes in HNE immunoreactivity were paralleled by changes in cytoplasmic phospholipase A2 (cPLA2) labeling in the pyramidal neurons in adjacent sections, suggesting that some of the HNE could have arisen as a result of peroxidation of arachidonic acid that was released by cPLA2. Interestingly, despite the HNE and cPLA2 labeling, no loss of neurons was observed in adjacent Nissl and Fluoro-Jade stained sections. Electron microscopy also showed that the HNE or cPLA2 labeled cells had features of injured neurons, rather than necrotic neurons. The reduction of HNE immunoreactivity in neurons at 14 days after oxidative injury, and the absence of cell loss at any of the time intervals, shows that hippocampal pyramidal neurons have remarkable ability to recover from a single episode of oxidative stress, if repeated injury such as seizures / excitotoxicity could be avoided.


Subject(s)
Aldehydes/metabolism , Citrates/pharmacology , Ferrous Compounds/pharmacology , Nerve Degeneration/metabolism , Oxidative Stress , Phospholipases A/metabolism , Pyramidal Cells , Animals , Immunohistochemistry , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Microscopy, Electron , Oxidative Stress/drug effects , Phospholipases A/drug effects , Phospholipases A2 , Pyramidal Cells/enzymology , Pyramidal Cells/pathology , Pyramidal Cells/ultrastructure , Random Allocation , Rats , Rats, Wistar
4.
J Neurocytol ; 34(6): 447-58, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16902765

ABSTRACT

The present study was carried out to elucidate the distribution of calcium-independent phospholipase A(2) (iPLA(2)) in the normal monkey brain. iPLA(2) immunoreactivity was observed in structures derived from the telencephalon, including the cerebral neocortex, amygdala, hippocampus, caudate nucleus, putamen, and nucleus accumbens, whereas structures derived from the diencephalon, including the thalamus, hypothalamus and globus pallidus were lightly labeled. The midbrain, vestibular, trigeminal and inferior olivary nuclei, and the cerebellar cortex were densely labeled. Immunoreactivity was observed on the nuclear envelope of neurons, and dendrites and axon terminals at electron microscopy. Western blot analysis showed higher levels of iPLA(2) protein in the cytosolic, than the nuclear fraction, but little or no protein in the membrane fraction. Similarly, subcellular fractionation studies of iPLA(2) activity in rat brain cortical cell cultures showed greater enzymatic activity in the cytosolic, than the nuclear fraction, and the least activity in non-nuclear membranes. The association of iPLA(2) with the nuclear envelope suggests a role of the enzyme in nuclear signaling, such as during neuronal proliferation and differentiation or death. In addition, the localization of iPLA(2) in dendrites and axon terminals suggests a role of the enzyme in neuronal signaling.


Subject(s)
Brain/enzymology , Phospholipases A/metabolism , Active Transport, Cell Nucleus/physiology , Animals , Brain/ultrastructure , Brain Chemistry , Cell Compartmentation/physiology , Cytosol/enzymology , Cytosol/ultrastructure , Dendrites/enzymology , Dendrites/ultrastructure , Female , Group VI Phospholipases A2 , Immunohistochemistry , Macaca fascicularis , Male , Microscopy, Electron, Transmission , Nuclear Envelope/enzymology , Nuclear Envelope/ultrastructure , Phospholipases A2 , Presynaptic Terminals/enzymology , Presynaptic Terminals/ultrastructure , Signal Transduction/physiology , Species Specificity , Subcellular Fractions/metabolism , Subcellular Fractions/ultrastructure
5.
Pain ; 112(1-2): 148-55, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15494195

ABSTRACT

The present study was carried out, using inhibitors to secretory phospholipase A2 (sPLA2, 12-epi-scalaradial), cytosolic phospholipase A2 (cPLA2, AACOCF3), or calcium-independent phospholipase A2 (iPLA2, bromoenol lactone), to compare possible contributions of central nervous PLA2 isoforms to the development of allodynia after facial carrageenan injection in mice. C57BL/6J (B6) mice showed increased responses to facial stimulation using a von Frey hair (1 g force), at 8 h, 1 day, and 3 days after facial carrageenan injection. On the other hand, BALB/c mice did not show increased responses at any of the time points. In both B6 and BALB/c mice, intracerebroventricular injection of inhibitors to each of the three PLA2 isoforms significantly reduced responses to von Frey hair stimulation at 8 h and 1 day after facial carrageenan injection, but at 3 days after injection, only the sPLA2 inhibitor had an effect. Since BALB/c mice did not show increased responses after facial carrageenan injection, the reduction in responses actually indicates that there is loss of normal sensitivity to von Frey hair stimulation after intracerebroventricular injection of each of these inhibitors, in this strain of mice. The effects of PLA2 inhibitors are unlikely to be due simply to inhibition of arachidonic acid generation, since intracerebroventricular injection of arachidonic acid also had an anti-nociceptive effect. The above results support an important role of central nervous PLA2s in neurotransmission and pain transmission.


Subject(s)
Carrageenan/toxicity , Enzyme Inhibitors/administration & dosage , Facial Pain/chemically induced , Facial Pain/drug therapy , Pain/drug therapy , Pain/enzymology , Phospholipases A/antagonists & inhibitors , Animals , Arachidonic Acids/administration & dosage , Facial Pain/enzymology , Injections, Intraventricular , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Pain/chemically induced , Phospholipases A/metabolism , Phospholipases A2
SELECTION OF CITATIONS
SEARCH DETAIL